Hosted on MSN11d
Jim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’
Jim Cramer, host of Mad Money, recently discussed some of the ... alcohol consumption and the increased risk of various ...
8 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently discussed some of the significant challenges the alcohol industry is facing.
TheStreet.com5y
Two Pharmaceutical Stocks That Jim Cramer's Watching
The reason Cramer's got Merck on the mind? Well, it's simple, really. The drug pricing debate is circulating around cancer drugs, which is something that Merck has a focus on. Here's what ...
Amgen Inc. (AMGN): ‘Absurd That This Stock Sells for 14x Earnings’ – Jim Cramer on Blockbuster Drugs
We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...
Insider Monkey on MSN10d
Jim Cramer on Keysight Technologies, Inc. (KEYS): ‘We Want This One’
Jim Cramer, host of Mad Money, recently discussed some of the ... alcohol consumption and the increased risk of various ...
Jim Cramer’s Game Plan: 15 Stocks in Focus
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...
Yahoo Finance22d
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’
Jim Cramer, host of Mad Money ... Beyond GLP-1 drugs, healthcare companies are expanding their portfolios with new cancer therapies, treatments for eye care and asthma, and experimental drugs ...